Where is the ovulation-inducing injection administered?

The purpose of administering ovulation-inducing injections is to stimulate the body to promptly release high-quality oocytes (eggs), thereby facilitating a smoother in vitro fertilization (IVF) process. Therefore, such injections are essential.

Where Are Ovulation-Inducing Injections Administered?

These injections are typically administered intramuscularly into the gluteal region (buttocks). Generally, the decision to administer the injection—and its dosage—is made only after ultrasound monitoring confirms follicular development. If follicular quality is satisfactory, the dose may be reduced; conversely, it may need to be increased if development is suboptimal. Consequently, reputable hospitals strictly regulate the use of such medications. Since healthy adult women normally ovulate only one egg per menstrual cycle, prolonged or inappropriate use of ovulation-inducing agents can adversely affect health. Additionally, during ovarian stimulation, patients should maintain regular sleep-wake cycles, avoid excessive physical exertion, and follow scientifically balanced dietary practices. However, these medications are contraindicated in patients with conditions such as ovarian insufficiency, polycystic ovary syndrome (PCOS), intracranial lesions, or hypothyroidism or adrenal cortical insufficiency.

Additional Information: What Are the Side Effects of Ovulation-Inducing Medications?

1. Hepatic and Renal Impairment

Ovulation-inducing medications are effective therapeutic agents that help women with anovulatory infertility—often caused by menstrual disorders—achieve pregnancy. However, since healthy adult women typically release only one egg per month, artificially stimulating multiple ovulations may lead to ovarian hyperstimulation syndrome (OHSS), manifesting as dizziness, nausea, and potentially causing hepatic or renal dysfunction.

2. Gynecological Complications

These medications may trigger various complications. In otherwise healthy individuals, sudden surges in ovulation can overwhelm normal physiological adaptation, leading to additional adverse events—including ovarian cysts, ovarian rupture, thromboembolism, electrolyte imbalances, and OHSS. Such complications may result in hepatic or renal failure, pleural effusion, or ascites in pregnant women; severe cases may even necessitate limb amputation or precipitate shock.

The above outlines the typical administration site for ovulation-inducing injections. We hope this information proves helpful to you.